Carregant...
Long‐acting beta2‐agonists as an inhaled corticosteroid‐sparing agent for chronic asthma in adults and children
BACKGROUND: The addition of a long acting beta agonist (LABA) to inhaled corticosteroid (ICS) therapy can improve asthma symptoms and reduce exacerbations. The addition of LABA may also have an ICS‐sparing effect and permit a reduction in ICS maintenance dose. OBJECTIVES: To determine the efficacy o...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2005
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387286/ https://ncbi.nlm.nih.gov/pubmed/16235393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005076.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|